Quarterly report pursuant to Section 13 or 15(d)

Description of Business and Summary of Significant Accounting Policies (Tables)

v3.10.0.1
Description of Business and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of antidilutive securities excluded from computation of earnings per share

    June 30,
2018
    June 30,
2017
 
Options     5,800,742       6,988,886  
Warrants     56,015,610       8,945,388  
Total     61,816,352       15,934,274  
Schedule of impacts to consolidated statements of cash flows
    Previously Reported     Adjustment     As Revised  
Net cash provided by (used in) investing activities   $ (372,802 )   $ 356,092     $ (16,710 )
Summary of cash and cash equivalent and restricted cash
    June 30,
2018
    December 31,
2017
 
Cash and cash equivalent   $ 21,474,264     $ 17,399,636  
Restricted cash – current     40,034       -  
Restricted cash     390,940       390,940  
Cash and cash equivalent and restricted cash   $ 21,905,238     $ 17,790,576